Portrait Antonio Giulio Gennari

Antonio Giulio
Gennari

PhD Student in Clinical Science
Forschungsgebiet: MRI features and cognitive correlates of focal lesional epilepsy
Akademischer Werdegang
  • 08 Aug 2013 – 08 Aug 2018: Residency in Clinical Radiology (5 years of training) at Department of Radiology – Cattinara University Hospital/University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy Research thesis: “Role of cortical and subcortical networks in determining aphasia, in Patients with left hemisphere gliomas”
  • 26 Sept 2012 – 07 Aug 2013: Internship in Clinical Radiology at Department of Radiology – Cattinara University Hospital/University of Trieste (Italy), Strada di Fiume 447, 34149 Trieste, Italy.
  • 22 Feb 2013: Professional licensure to practice Ordine provinciale dei Medici – Chirurghi e degli Odontoiatri di Trieste Registration number: 4285. Date of registration: 22 Feb 2013
  • Sept 2005 – Sept 2012: Medical School at University of Trieste, Italy
  • 25th September 2012: medical degree cum laudae (MB ChB equivalent) Research thesis: “Advanced MR imaging techniques in the evaluation of the response to neoadjuvant chemoradiation therapy in patients with rectal cancer”
Preise und Ehrungen
  • 2020 ESR European Radiology Review Fellowship winner
    The fellowship aims to familiarise trainees to manuscript handling, methods for analysing scientific papers and criteria for editorial decision
  • Award for the best oral presentation at 2016 SIRM Regional Congress, with the communication: “Differentiation of Responders from Non responders among Patients with Clinically Active Crohn Disease after 6 Weeks of Pharmacologic Treatment”
  • 2016 Pacor’s Award winner 
    The Pacor’s award is sponsored by Rotary Club of Trieste and dedicated to innovative research projects in oncologic field
  • Award for the best oral gastrointestinal presentation at 2016 SIRM National Gastrointestinal Congress in Ferrara, with the communication: “The early differentiation of responders from non-responders among patients with active Crohn’s disease undergoing pharmacologic treatment through analysis of time-intensity curves obtained after microbubble contrast agent injection”
     
Mitgliedschaften
  • SIRM (2013 - 2021)
  • ESR (2015 - 2021)
  • RSNA (2015 - 2020)
  • CIRSE (2016 - 2017)
  • ESHI (2017 - 2018)
  • ESOI (2018 - 2020)
     
Eingeworbene Drittmittel

2021 Swiss Government Excellence Scholarship